Soley Therapeutics raises $200M Series C

Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs. The company announced a $200M Series C on January 7, 2026, from its base in San Francisco, US. Investors and valuation were not disclosed in Crunchbase's round record; Lounge adds them as they are reported. It has raised more than $100M in total venture funding.